Sangeeta Bhorade to Lung Neoplasms
This is a "connection" page, showing publications Sangeeta Bhorade has written about Lung Neoplasms.
Connection Strength
0.239
-
Clinical validation and utility of Percepta GSC for the evaluation of lung cancer. PLoS One. 2022; 17(7):e0268567.
Score: 0.084
-
Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study. BMC Pulm Med. 2022 Jan 06; 22(1):26.
Score: 0.081
-
Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study. Chest. 2021 01; 159(1):401-412.
Score: 0.073